Rongtai Health: Intends to cancel 2.3032 million repurchased shares, reducing registered capital.

Rongtai Health announced that the company held separate board meetings and extraordinary general meetings in 2025, agreeing to reclassify the 2.3032 million shares repurchased in 2023 for cancellation and reduction of registered capital, accounting for 1.13% of the total share capital before cancellation. After this cancellation, the company's total share capital will be reduced from 203 million shares to 201 million shares, with corresponding changes in registered capital. The company has completed the notification process for creditors and has not received any objections. The cancellation of repurchased shares is scheduled to be completed on February 3, 2026. After the cancellation, the controlling shareholder and actual controller of the company remain unchanged, and the distribution of equity still meets the listing requirements.